Monika Čáni, Júlia Lucká, Tibor Malacký
In April of this year, 10 years have passed since the first TAVI was performed in our institution (NÚSCH, a.s., Bratislava). Preference is given to the transfemoral approach for fewer complications and shorter convalescence. Transfemoral TAVI is indicated for patients aged 75 or older, with moderate or high operational risk, with a suitable transfemoral approach. The indication is decided by the “Heart Team”. An essential condition is the presence of cardiac surgery support. The most common complications are paravalvular regurgitation (in our sample, this included 12% of moderate and severe paravalvular regurgitation 12 months after the treatment), and the necessity of a pacemaker implantation (25% of patients in our sample). Recent studies have demonstrated non-inferiority to superiority of TAVI over aortic valve replacement surgery in patients with low surgical risk and this shows a trend for the future.